Comments on: A Phase 3b Study to Evaluate Efficacy and Safety of a Single Dose of Autologous CRISPR Cas9 Modified CD34+ Human Hematopoietic Stem and Progenitor Cells (CTX001) in Subjects With Transfusion-Dependent β-Thalassemia or Severe Sickle Cell Disease

Comments on: A Phase 3b Study to Evaluate Efficacy and Safety of a Single Dose of Autologous CRISPR Cas9 Modified CD34+ Human Hematopoietic Stem and Progenitor Cells (CTX001) in Subjects With Transfusion-Dependent β-Thalassemia or Severe Sickle Cell Disease https://scdstudies.com/a-phase-3b-study-to-evaluate-efficacy-and-safety-of-a-single-dose-of-autologous-crispr-cas9-modified-cd34-human-hematopoietic-stem-and-progenitor-cells-ctx001-in-subjects-with-transfusion-dependent/?utm_source=rss&utm_medium=rss&utm_campaign=a-phase-3b-study-to-evaluate-efficacy-and-safety-of-a-single-dose-of-autologous-crispr-cas9-modified-cd34-human-hematopoietic-stem-and-progenitor-cells-ctx001-in-subjects-with-transfusion-dependent Fri, 14 Jun 2024 12:18:22 +0000 hourly 1 https://wordpress.org/?v=6.7.1